Could the next therapy for COVID-19 already be at your local pharmacy?

For people with psoriasis, finding a way to reduce inflammation could be a game changer. A new U-M study provides hope for those living with the autoimmune disorder.

A new Michigan Medicine study shows promising results in use of tofacitinib in treatment of acute severe ulcerative colitis (ASUC) to reduce colectomy.

A protein called PIKfyve impacts multiple processes involved in metabolism and cell death; blocking it is key to making immunotherapy work in prostate cancer.

Gun violence is the leading cause of death for high school aged teens in America, but more parents of teens, including teens with depression, are buying guns during the pandemic. Public health officials stress the importance of safely securing firearms in

For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.

The finding will likely help physicians develop targeted therapies for future COVID patients.  Pull Quote text (255 max): “Studying these COVID-induced antibodies will also teach us about the mechanisms of autoimmunity in general, espe

A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.

A liver specialist teams up with a nutrition epidemiologist to examine the direct impact of consuming sugar-sweetened beverages on developing liver disease.

Variants of SARS-CoV-2, the virus behind COVID-19, continue to emerge. Michigan Medicine experts explain what that means for COVID vaccine efficacy and current treatments.

A new blood test could give doctors more time to try alternative treatments for HPV-positive throat cancer by signaling whether initial treatment is effective much earlier than current diagnostic tests.

The algorithm is currently implemented at hundreds of U.S. hospitals.

Some prostate tumors transition from being glandular to more nerve-like in response to drugs that block the androgen receptor; a new preclinical study examines the underlying mechanisms and uncovers a promising countermeasure.

New technique visualizes all gene expression from a tissue.

A research team from Michigan Medicine has developed a new potential treatment for fatty liver disease in patients with partial lipodystrophy and/or NASH.